Frontlight ResearchEarly access
Spinal muscular atrophy trials in Belgium
5 of 5 trials · From ClinicalTrials.gov and EU CTIS (euclinicaltrials.eu), checked 18 November 2026. Ask the study team whether a trial fits you.
- Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Gent, Leuven, Liège
- Age
- Up to 17 years
- People
- 30 worldwide
- Run by
- Scholar Rock Inc.
See details and how to join2024-520130-29-00 - No phaseTaking peopleSMAdult - Monitoring of Movement on Spinal Muscular Atrophy
- Where
- Liège
- Age
- 15 years and over
- People
- 60
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT07894185 - Phase 3Not yet taking people in BelgiumA Study to Learn About the Safety and Effects of Salanersen (BIIB115) When Given to Babies With Spinal Muscular Atrophy (SMA) Who Were Previously Treated With Onasemnogene Abeparvovec
- Where
- Gent
- Age
- 0 days to 7 months
- People
- 42 worldwide
- Run by
- Biogen
See details and how to joinNCT07444450 · EU 2025-523857-32-00 - Phase 2Taking peopleA Study to Evaluate How Apitegromab Works in Subjects Who Are Less Than 2 Years Old and Have Spinal Muscular Atrophy
- Where
- Ghent, Leuven, Liège
- Age
- Up to 2 years
- People
- 52 worldwide
- Run by
- Scholar Rock, Inc.
See details and how to joinNCT07047144 - No phaseTaking peopleActive NBS Study: Decentralised Monitoring Motor Development in Children With Duchenne Muscular Dystrophy or Spinal Muscular Atrophy Identified by Newborn Screening
- Where
- Liège
- Age
- 4 months and over
- People
- 100
- Run by
- Centre Hospitalier Universitaire de Liege
See details and how to joinNCT07286565